DePuy Mitek
CompanyUnited States
DePuy Mitek develops one asset, in phase 3 (Orthovisc in aesthetic). Mostly other acting on CD44; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 3
- 1
- Trial
- 0
- Signals
Pipeline
1Dermal filler providing structural support and tissue augmentation
Phase 3, Other, CD44, aesthetic, facial aesthetic treatment
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials1
- Similar companies4